Campylobacter fetus ssp jejuni: isolation from patients with gastroenteritis.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 7466431)

Published in South Med J on February 01, 1981

Authors

D W Lambe, D A Ferguson, S L Wiener, J P Butzler

Articles citing this

Differentiation of Campylobacter species by protein banding patterns in polyacrylamide slab gels. J Clin Microbiol (1984) 1.20

Antibiotics in general practice. J R Coll Gen Pract (1982) 0.75

Articles by these authors

Campylobacter enteritis. Clin Gastroenterol (1979) 18.67

Related vibrio in stools. J Pediatr (1973) 12.85

Acute enteritis due to related vibrio: first positive stool cultures. J Infect Dis (1972) 9.82

Campylobacter enteritis in Brussels. Lancet (1978) 6.37

Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents. Antimicrob Agents Chemother (1978) 5.42

Enteritis due to "related vibrio" in children. Am J Dis Child (1973) 5.04

Rapid susceptibility testing of Mycobacterium tuberculosis by a radiometric technique. J Antimicrob Chemother (1982) 3.52

Campylobacter serotyping a epidemiology. Lancet (1981) 3.18

Streptobacillus moniliformis isolated from a case of Haverhill fever: biochemical characterization and inhibitory effect of sodium polyanethol sulfonate. Am J Clin Pathol (1973) 2.96

Female prostitutes: a risk group for infection with human T-cell lymphotropic virus type III. Lancet (1985) 2.84

Evaluation of Pseudosel agar as an aid in the identification of Pseudomonas aeruginosa. Appl Microbiol (1972) 2.81

Letter: Related vibrios in Africa. Lancet (1973) 2.76

Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni. Antimicrob Agents Chemother (1980) 2.71

Postnatal transmission of HIV from mother to child. Lancet (1987) 2.60

Serogrouping of Bacteroides fragilis subsp. fragilis by the agglutination test. J Clin Microbiol (1976) 2.42

Determination of Bacteroides melaninogenicus serogroups by fluorescent antibody staining. Appl Microbiol (1974) 2.41

Susceptibility of related vibrios and Vibrio fetus to twelve antibiotics. Antimicrob Agents Chemother (1974) 2.41

Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens. Antimicrob Agents Chemother (1985) 2.36

Modified selective medium for isolation of Campylobacter spp. from feces: comparison with Preston medium, a blood-free medium, and a filtration system. J Clin Microbiol (1986) 2.25

Outbreak of recurrent abdominal cramps associated with Arcobacter butzleri in an Italian school. J Clin Microbiol (1992) 2.11

Nontypeable Haemophilus influenzae in the elderly. Arch Intern Med (1982) 2.06

Acquired immunodeficiency syndrome in Rwanda. Lancet (1984) 2.05

Campylobacter upsaliensis enteritis associated with canine infections. Lancet (1991) 2.05

A new selective medium for the isolation of Campylobacter jejuni from human faeces. Eur J Clin Microbiol (1983) 2.03

Clinical comparison of aerobic, hypertonic, and anaerobic culture media for the radiometric detection of bacteremia. J Clin Microbiol (1976) 1.94

Differentiated Caco-2 cells as a model for enteric invasion by Campylobacter jejuni and C. coli. J Med Microbiol (1992) 1.91

Routine culture of Giardia lamblia trophozoites from human duodenal aspirates. Lancet (1984) 1.86

Community-acquired bacteremia among hospitalized children in rural central Africa. Int J Infect Dis (2001) 1.76

Diagnosis of Helicobacter pylori infection by PCR: comparison with other invasive techniques and detection of cagA gene in gastric biopsy specimens. J Clin Microbiol (1995) 1.72

Evaluation of a worksite programme for the modification of cardiovascular risk factors. Med J Aust (1989) 1.70

"RSI": putting the epidemic to rest. Med J Aust (1987) 1.69

Detection of 4-quinolone resistance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR. Antimicrob Agents Chemother (1994) 1.66

Community-acquired bacteraemia in African children. Lancet (1987) 1.61

Campylobacter enteritis and erythema nodosum. Lancet (1982) 1.59

Accuracy and reproducibility of precordial percussion and palpation for detecting increased left ventricular end-diastolic volume and mass. A comparison of physical findings and ultrafast computed tomography of the heart. JAMA (1993) 1.54

Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure. J Am Coll Cardiol (1998) 1.53

Susceptibility pattern of Campylobacter jejuni from human and animal origins to different antimicrobial agents. Antimicrob Agents Chemother (1982) 1.52

Detection of HIV p17 antigen in lymphocytes but not epithelial cells from cervicovaginal secretions of women seropositive for HIV: implications for heterosexual transmission of the virus. Genitourin Med (1988) 1.45

Evaluation of a commercially available second-generation immunoglobulin G enzyme immunoassay for detection of Helicobacter pylori infection. J Clin Microbiol (1992) 1.38

[Digestive origin of Campylobacter septicemias]. Nouv Presse Med (1977) 1.37

Bacterial adherence and glycocalyx formation in osteomyelitis experimentally induced with Staphylococcus aureus. Infect Immun (1984) 1.36

A newly developed PCR assay of H. pylori in gastric biopsy, saliva, and feces. Evidence of high prevalence of H. pylori in saliva supports oral transmission. Dig Dis Sci (1996) 1.36

Enteropathogenic agents in children with diarrhoea in rural Zaire. Lancet (1983) 1.35

Is "Campylobacter upsaliensis" an unrecognised cause of human diarrhoea? Lancet (1990) 1.32

The immune response in a patient to an infection with Bacteroides fragilis ss. fragilis and Clostridium difficile. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 1.31

Electrophoretic protein patterns and enzyme mobilities in anaerobic coryneforms. Appl Environ Microbiol (1978) 1.30

Failure of live, attenuated oral rotavirus vaccine. Lancet (1986) 1.30

Campylobacter pyloridis in children. Lancet (1986) 1.28

Effect of beta-adrenergic receptor blockade on racing performance of greyhounds with normal and with denervated hearts. Circ Res (1968) 1.27

Semisolid selective-motility enrichment medium for isolation of salmonellae from fecal specimens. J Clin Microbiol (1984) 1.23

Description of a polyvalent conjugate and a new serogroup of Bacteroides melaninogenicus by fluorescent antibody staining. J Clin Microbiol (1976) 1.22

Campylobacter jejuni post-transfusional septicaemia. Lancet (1979) 1.20

Differentiation of Campylobacter species by protein banding patterns in polyacrylamide slab gels. J Clin Microbiol (1984) 1.20

Stomatitis with septicemia due to Moraxella osloensis. J Pediatr (1974) 1.20

Molecular epidemiological study of nosocomial Enterobacter aerogenes isolates in a Belgian hospital. J Clin Microbiol (1998) 1.19

The mechanism of action of a single dose of methylprednisolone on acute inflammation in vivo. J Clin Invest (1975) 1.18

Semisolid blood-free selective-motility medium for the isolation of campylobacters from stool specimens. J Clin Microbiol (1989) 1.18

Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail (1998) 1.17

Relationship between lung asbestos fiber type and concentration and relative risk of mesothelioma. A case-control study. Cancer (1991) 1.17

Characterization of Bacteroides gingivalis by direct fluorescent antibody staining and cellular fatty acid profiles. Can J Microbiol (1982) 1.17

Isolation of penicillin and streptomycin resistant strains of Moraxella osloensis. Acta Pathol Microbiol Scand B Microbiol Immunol (1974) 1.16

High prevalence of Helicobacter pylori in saliva demonstrated by a novel PCR assay. J Clin Pathol (1995) 1.15

Comparison of six serological assays for human immunodeficiency virus antibody detection in developing countries. J Clin Microbiol (1988) 1.15

Differentiation of Helicobacter pylori strains directly from gastric biopsy specimens by PCR-based restriction fragment length polymorphism analysis without culture. J Clin Microbiol (1997) 1.10

Epidemiologic characteristics of women infected with Corynebacterium vaginale (Haemophilus vainalis). J Am Vener Dis Assoc (1976) 1.10

Inhibiting early activation of tissue nuclear factor-kappa B and nuclear factor interleukin 6 with (1-->3)-beta-D-glucan increases long-term survival in polymicrobial sepsis. Surgery (1999) 1.09

Immune responses in eight patients infected with Bacteroides fragilis. J Infect Dis (1975) 1.09

New selective medium for isolation of Campylobacter jejuni from faecal specimens. Lancet (1983) 1.08

The diagnostic usefulness of the history of the patient with dyspnea. J Gen Intern Med (1987) 1.08

Paediatric campylobacter diarrhoea from household exposure to live chickens in Lima, Peru. Bull World Health Organ (1988) 1.08

The incidence of the hypothenar hammer syndrome. Arch Surg (1972) 1.07

Campylobacter enteritis. Acta Paediatr Belg (1979) 1.06

Disk sensitivity testing for Campylobacter jejuni. Eur J Clin Microbiol (1984) 1.06

Twelve year observation of primary and secondary antibiotic-resistant Helicobacter pylori strains in children. Pediatr Infect Dis J (2001) 1.06

Evaluation of a new method for routine in vitro cultivation of Giardia lamblia from human duodenal fluid. J Clin Microbiol (1985) 1.06

A highly specific and sensitive DNA probe derived from chromosomal DNA of Helicobacter pylori is useful for typing H. pylori isolates. J Clin Microbiol (1993) 1.06

Kinetics of anti-Campylobacter jejuni monomeric and polymeric immunoglobulin A1 and A2 responses in serum during acute enteritis. J Clin Microbiol (1987) 1.05

In vitro susceptibilities of 25 Giardia lamblia isolates of human origin to six commonly used antiprotozoal agents. Antimicrob Agents Chemother (1985) 1.05

Similarity of blood flow in the normal and the sympathectomized dog hind limb during graded exercise. Circ Res (1970) 1.04

Yersinia pseudotuberculosis septicaemia in thalassaemia major. Lancet (1984) 1.04

Use of ceftazidime in the therapy of serious infections, including those due to multiresistant organisms. Antimicrob Agents Chemother (1983) 1.04

Effect of antimicrobial therapy on the specific serological response to Helicobacter pylori infection. Eur J Clin Microbiol Infect Dis (1992) 1.03

In-vitro activity of new cephalosporin (HR 756) and cefazolin. Lancet (1978) 1.03

Comparison of the pathogenicity of three species of coagulase-negative Staphylococcus in a mouse model with and without a foreign body. Can J Microbiol (1991) 1.02

Proposed standardized method for testing and interpreting susceptibility of Bacteroides fragilis to tetracycline. Antimicrob Agents Chemother (1974) 1.02

Nutritional requirements of anaerobic coryneforms. J Bacteriol (1978) 1.01

Corynebacterium vaginale (Haemophilus vaginalis) in women with leukorrhea. Am J Obstet Gynecol (1976) 1.01

Evaluation and simplification of the World Health Organization clinical case definition for paediatric AIDS. AIDS (1989) 0.99

Early activation of hepatic NFkappaB and NF-IL6 in polymicrobial sepsis correlates with bacteremia, cytokine expression, and mortality. Ann Surg (1999) 0.99

Severe multiresistant Salmonella typhimurium systemic infections in Central Africa--clinical features and treatment in a paediatric department. J Antimicrob Chemother (1984) 0.97

Chronic perceived work stress and blood pressure among Australian government employees. Scand J Work Environ Health (1990) 0.96

Brucella melitensis: person-to-person transmission? Lancet (1983) 0.96

An electron microscopic study of the effect of clindamycin on adherence of Staphylococcus aureus to bone surfaces. Microbios (1986) 0.95

The role of the oral cavity in Helicobacter pylori infection. Am J Gastroenterol (1997) 0.94

Ward rounds revisited--the validity of the data base. J Med Educ (1974) 0.93

Staphylococcal exopolysaccharides inhibit lymphocyte proliferative responses by activation of monocyte prostaglandin production. Infect Immun (1992) 0.93

Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid. J Antimicrob Chemother (1987) 0.92

In-vitro susceptibility of salmonellae to antimicrobial agents. J Antimicrob Chemother (1984) 0.92

Molecular characterization of resistance plasmids in epidemiologically unrelated strains of multiresistant Haemophilus influenzae. J Infect Dis (1993) 0.92